BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally-driven diseases, today announced that management will present at three upcoming investor conferences:
• 2015 Credit Suisse Healthcare Conference on Wednesday, November 11, 2015 at 2:30pm MT, at The Phoenician in Phoenix, Arizona
Help employers find you! Check out all the jobs and post your resume.
